[
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Ascends But Remains Behind Market: Some Facts to Note",
    "summary": "In the most recent trading session, Johnson & Johnson (JNJ) closed at $145.27, indicating a +0.55% shift from the previous trading day.",
    "url": "https://finnhub.io/api/news?id=b746eaeb0462717de601414acddc73104362365add92066f315239d33828a48d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734993918,
      "headline": "Johnson & Johnson (JNJ) Ascends But Remains Behind Market: Some Facts to Note",
      "id": 132129568,
      "image": "https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "In the most recent trading session, Johnson & Johnson (JNJ) closed at $145.27, indicating a +0.55% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=b746eaeb0462717de601414acddc73104362365add92066f315239d33828a48d"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson stock rises Monday, still underperforms market",
    "summary": "Johnson & Johnson stock rises Monday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=144c41b23852ee30acc7696401be6d7d467a14c7bb84dfb639ed2771f958c0dc",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734971460,
      "headline": "Johnson & Johnson stock rises Monday, still underperforms market",
      "id": 132145990,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson stock rises Monday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=144c41b23852ee30acc7696401be6d7d467a14c7bb84dfb639ed2771f958c0dc"
    }
  },
  {
    "ts": null,
    "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "summary": "Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.",
    "url": "https://finnhub.io/api/news?id=88c1ebdd346f4306254e3ccf3bb3703489bd731eabd078564e0df900817876aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734962405,
      "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
      "id": 132120108,
      "image": "https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.",
      "url": "https://finnhub.io/api/news?id=88c1ebdd346f4306254e3ccf3bb3703489bd731eabd078564e0df900817876aa"
    }
  },
  {
    "ts": null,
    "headline": "Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?",
    "summary": "Sector ETF report for IHE",
    "url": "https://finnhub.io/api/news?id=7c438cd9ee8d177ccfde9a4b2abe54617846a9612eb9956e3d6ea3a18939cc84",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734952806,
      "headline": "Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?",
      "id": 132120109,
      "image": "https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Sector ETF report for IHE",
      "url": "https://finnhub.io/api/news?id=7c438cd9ee8d177ccfde9a4b2abe54617846a9612eb9956e3d6ea3a18939cc84"
    }
  },
  {
    "ts": null,
    "headline": "A Bull Market Is Here: 2 Super Stocks Down 21% and 30% to Buy Right Now",
    "summary": "Meanwhile, the more growth-heavy Nasdaq Composite index has delivered a total return of 30%.  This year's performance has marked one of the most impressive annual bull runs in stock market history, and major indexes have managed to notch new highs at multiple points across the stretch.  Keith Noonan: Uber Technologies (NYSE: UBER) is the leader in the ride-hailing market, and it's been serving up some pretty impressive sales and margin growth.",
    "url": "https://finnhub.io/api/news?id=24e207b493431cd3c62377e59572f417165760b7c212f5ebdbcd3cfd48c3c10a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734949500,
      "headline": "A Bull Market Is Here: 2 Super Stocks Down 21% and 30% to Buy Right Now",
      "id": 132117420,
      "image": "https://g.foolcdn.com/editorial/images/801656/gettyimages-1686497935.jpg",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Meanwhile, the more growth-heavy Nasdaq Composite index has delivered a total return of 30%.  This year's performance has marked one of the most impressive annual bull runs in stock market history, and major indexes have managed to notch new highs at multiple points across the stretch.  Keith Noonan: Uber Technologies (NYSE: UBER) is the leader in the ride-hailing market, and it's been serving up some pretty impressive sales and margin growth.",
      "url": "https://finnhub.io/api/news?id=24e207b493431cd3c62377e59572f417165760b7c212f5ebdbcd3cfd48c3c10a"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Equity Income Fund Q3 2024 Commentary",
    "summary": "Hartford Equity Income Fund (I Share) underperformed the Russell 1000 Value Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=4490c5102366252755ca7a7f6f527f692cd256f570bb1f2f364a69ee5c8fa307",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734947160,
      "headline": "Hartford Equity Income Fund Q3 2024 Commentary",
      "id": 132119127,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2095584352/image_2095584352.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Hartford Equity Income Fund (I Share) underperformed the Russell 1000 Value Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=4490c5102366252755ca7a7f6f527f692cd256f570bb1f2f364a69ee5c8fa307"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Healthcare Fund Q3 2024 Commentary",
    "summary": "The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=437ec63326aa68c908ac079db97d70f4234eaaad235650d5fe23a7620a6c7827",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734930900,
      "headline": "Hartford Healthcare Fund Q3 2024 Commentary",
      "id": 132116815,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2154850841/image_2154850841.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=437ec63326aa68c908ac079db97d70f4234eaaad235650d5fe23a7620a6c7827"
    }
  }
]